Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 32, 2024 - Issue 1
Submit an article Journal homepage
92
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Clinical Report of the Effectiveness of Netasurdil in Patients with Uveitic Glaucoma

Marko OydanichInstitute of Ophthalmology & Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, USAView further author information
, MD, MS,
Elizabeth H. RollInstitute of Ophthalmology & Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, USAView further author information
, MD,
Siri UppuluriInstitute of Ophthalmology & Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, USAView further author information
, BA &
Albert S. KhouriInstitute of Ophthalmology & Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, USACorrespondence[email protected]
View further author information
, MD
Pages 2-4 | Received 12 Jul 2022, Accepted 03 Nov 2022, Published online: 22 Nov 2022

References

  • Siddique SS, Suelves AM, Baheti U, Foster CS. Glaucoma and uveitis. Surv Ophthalmol. 2013;58:1–10. doi:10.1016/j.survophthal.2012.04.006.
  • Muñoz-Negrete FJ, Moreno-Montañés J, Hernández-Martínez P, Rebolleda G. Current approach in the diagnosis and management of uveitic glaucoma. Biomed Res Int. 2015;2015:742792. doi:10.1155/2015/742792.
  • Batra M, Gupta S, Nair AB, Dhanawat M, Sandal S, Morsy MA. Netarsudil: a new ophthalmic drug in the treatment of chronic primary open angle glaucoma and ocular hypertension. Eur J Ophthalmol. 2021;31:2237–2244. doi:10.1177/11206721211008783.
  • Khouri AS, Serle JB, Bacharach J, et al. Once-daily netarsudil versus twice-daily timolol in patients with elevated intraocular pressure: the randomized Phase 3 ROCKET-4 study. Am J Ophthalmol. 2019;204:97–104. doi:10.1016/j.ajo.2019.03.002.
  • Testa V, Ferro Desideri L, Della Giustina P, Traverso CE, Iester M. An update on ripasudil for the treatment of glaucoma and ocular hypertension. Drug Today. 2020;56:599–608. doi:10.1358/dot.2020.56.9.3178110.
  • Serle JB, Katz LJ, McLaurin E, et al. Two Phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: Rho kinase elevated IOP treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2). Am J Ophthalmol. 2018;186:116–127. doi:10.1016/j.ajo.2017.11.019.
  • Rapuano PB, Levin AV, Price JM, Myers JS, Lee D, Shukla AG. Early experience with netarsudil in pediatric patients: a retrospective case series. Ophthalmology Glaucoma. 2021;4:232–234. doi:10.1016/j.ogla.2020.10.005.
  • Kusuhara S, Katsuyama A, Matsumiya W, Nakamura M. Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma. Graefes Arch Clin Exp Ophthalmol. 2018;256:809–814. doi:10.1007/s00417-018-3933-9.
  • Futakuchi A, Morimoto T, Ikeda Y, et al., Yuasa Y and collaborators R-Ssg. Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glaucoma patients: ROCK-S, a multicentre historical cohort study. Sci Rep. 2020;10:10308. doi:10.1038/s41598-020-66928-4.
  • Markomichelakis NN, Kostakou A, Halkiadakis I, Chalkidou S, Papakonstantinou D, Georgopoulos G. Efficacy and safety of latanoprost in eyes with uveitic glaucoma. Graefes Arch Clin Exp Ophthalmol. 2009;247:775–780. doi:10.1007/s00417-009-1036-3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.